Lonza Completes InterHealth Nutraceuticals Buy

05:41 EDT 22 Sep 2016 | CHEManager

Swiss fine chemicals producer Lonza has closed the acquisition of US-based InterHealth Nutraceuticals from Kainos Capital for a price of up to $300 million, split into an upfront payment and an earn-out payment.

Original Article: Lonza Completes InterHealth Nutraceuticals Buy


More From BioPortfolio on "Lonza Completes InterHealth Nutraceuticals Buy"

Quick Search

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...